An ever growing number of people are interested in alternatives to conventional medicine because they want to be seen as a “whole” person rather than a „collection of organs“. Nevertheless, there are still many people who are skeptical of natural medicine. This is quite understandable since the differences between effective natural treatments and unnecessary “hocus pocus” can sometimes be difficult to recognize.
The best way to change attitudes toward natural medicine is through research based on scientific principles, because significant results will build trust. Unfortunately, little research in the field of natural medicine has been carried out thus far. One reason for this is that natural active ingredients often cannot be patented. Therefore, large companies cannot count on sufficient profits to justify the effort. Smaller companies, on the other hand, often do not possess the resources required for high quality research.
As a young and innovative company, Syntrion GmbH is committed to natural healing methods as well as research. To make this intention a reality Syntrion initiated a research program in cooperation with Professor Dr. Christopher Gerner at the University of Vienna’s Institute for Analytical Chemistry (formerly at the Cancer Research Institute of the Medical University of Vienna), along with the drug development program back in 2006. This cooperation allows Syntrion to work in a scientific environment with high-tech devices such as mass spectrometers and databases which are generally restricted to pharmaceutical giants with multimillion dollar revenues.